|
QualityMetric
Incorporated is the leading developer and provider of the SF
General Health Surveys:
SF-36®, SF-12®, and SF-8™ and other disease-specific health
surveys for clinical trials that require practical and precise
measures for risk screening and sensitive, patient-reported
outcomes measures.
Many drugs
and devices in the discovery and development pipeline hold great
promise for reducing the impact of chronic health problems on
everyday life. These drugs/devices also represent a significant
health care cost, making it incumbent on the pharmaceutical and
biotechnology industries to document health benefit.
QualityMetric
scientists have more than three decades of experience in the
development and application of patient-reported health outcomes
for clinical trials that:
- Quantify
the consumer's experience of improved health-related
quality of life (HRQOL)
- Deliver
proof of efficacy in a currency that goes beyond traditional
clinical endpoints
- Provides
a scientifically valid body of evidence to facilitate timely
regulatory approval
Our
pharmaceutical and biotechnology clients recognize the need to
define benefits more broadly than traditional clinical endpoints
by including patient-reported outcomes (PROs) in clinical trials.
Additional clinical evidence based on PROs also commands
increasing attention from the Food and Drug Administration (FDA),
making it critical to the drug review and approval process.
Our disease-specific
surveys can be used alone to screen for and monitor impact on
functional status and well-being, or paired with an SF
general health survey to capture a more comprehensive picture
of HRQOL benefits. Our surveys can be delivered in
fixed-length format for administration in paper-and pencil, by
telephone using speech recognition, on PDAs, and online. For
innovators, our online computer
adaptive software (DYNHA™) delivers surveys that offer
real-time, short yet precise assessments that yield our
pharmaceutical and biotechnology clients a strong return on
investment.
Many
pharmaceutical and biotechnology companies worldwide also utilize
QualityMetric's scientific expertise for consulting on the:
- Selection
of patient-reported outcomes measures for use in all phases of
drug/device development and testing
- Design
of clinical trials, data collection protocols, and analytic
plans
- Analyses
and re-analyses of clinical trials data
- Preparation
of abstracts, presentations, and manuscripts reporting results
from clinical trial analyses
For
information on any QualityMetric product or service, visit us at:
If you can
improve health care, QualityMetric will help you prove it.
|
